NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 309 filers reported holding NOVOCURE LTD in Q4 2022. The put-call ratio across all filers is 1.54 and the average weighting 0.2%.
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $650,162,811 | +95893.3% | 8,863,842 | -0.6% | 0.68% | -2.9% |
| Q3 2022 | $677,300 | +6.9% | 8,914,191 | -2.2% | 0.70% | +7.4% |
| Q2 2022 | $633,578 | -18.1% | 9,116,230 | -2.4% | 0.65% | +19.9% |
| Q1 2022 | $773,890 | +7.2% | 9,340,845 | -2.9% | 0.54% | +36.9% |
| Q4 2021 | $721,906 | -33.7% | 9,615,168 | +2.6% | 0.40% | -30.4% |
| Q3 2021 | $1,088,478 | -47.2% | 9,369,705 | +0.7% | 0.57% | -43.4% |
| Q2 2021 | $2,063,165 | +76.1% | 9,301,081 | +4.9% | 1.00% | +53.4% |
| Q1 2021 | $1,171,635 | -18.0% | 8,863,932 | +7.3% | 0.66% | -17.7% |
| Q4 2020 | $1,429,497 | +58.1% | 8,261,075 | +1.7% | 0.80% | +27.8% |
| Q3 2020 | $904,355 | +93.0% | 8,124,645 | +2.8% | 0.62% | +74.5% |
| Q2 2020 | $468,692 | -10.0% | 7,903,720 | +2.2% | 0.36% | -36.7% |
| Q1 2020 | $520,983 | -22.8% | 7,736,618 | -3.4% | 0.56% | -13.5% |
| Q4 2019 | $674,917 | +4.3% | 8,008,982 | -7.4% | 0.65% | -11.4% |
| Q3 2019 | $647,117 | +15.9% | 8,653,618 | -2.0% | 0.74% | +24.3% |
| Q2 2019 | $558,287 | +44.2% | 8,829,449 | +9.8% | 0.59% | +39.6% |
| Q1 2019 | $387,263 | +157.1% | 8,039,525 | +78.7% | 0.42% | +116.3% |
| Q4 2018 | $150,610 | -18.5% | 4,498,524 | +27.5% | 0.20% | -2.0% |
| Q3 2018 | $184,821 | +90.9% | 3,527,100 | +14.0% | 0.20% | +92.3% |
| Q2 2018 | $96,823 | +61.5% | 3,093,395 | +12.5% | 0.10% | +48.6% |
| Q1 2018 | $59,942 | +391.2% | 2,749,639 | +355.2% | 0.07% | +366.7% |
| Q4 2017 | $12,203 | – | 604,117 | – | 0.02% | – |
Download | ||||||